BSE : 530019
NSE : JUBLPHARMA
Sector :Health care
ISIN Code : INE700A01033
NSE
1069.80
-27.60 (-2.52%)
BSE
1073.25
-23.60 (-2.15%)
04:01 PM,26th Dec 2024
Outcome of the Board Meeting held on October 25 2024 - Approval of Unaudited Financial Results for quarter and half year ended September 30 2024